Checking for Immunity from Varicella (Chickenpox)
Varicella immunity should be assessed using a varicella IgG antibody test, preferably a commercial ELISA, which offers high specificity for screening purposes. 1
Evidence of Immunity to Varicella
Immunity to varicella can be established through any of the following:
- Laboratory evidence: Positive varicella IgG antibody test
- Documentation of vaccination: Written record of 2 doses of varicella vaccine
- Healthcare provider verification: Documented history of varicella disease or herpes zoster
- Laboratory confirmation: Previous laboratory-confirmed varicella or herpes zoster 1
Serological Testing Methods
Recommended Testing Approach
Commercial ELISA (Enzyme-Linked Immunosorbent Assay)
- Preferred for screening purposes due to higher specificity
- Less sensitive than other tests but more specific, reducing false positives
- Recommended particularly for healthcare personnel screening 1
Latex Agglutination (LA) Test
- More sensitive but may produce false-positive results
- Can be completed in 15 minutes
- Uses latex particles coated with VZV glycoprotein antigens
- Not recommended for routine screening due to documented cases of false positives leading to varicella infections in unvaccinated individuals 1
Test Performance Considerations
- Commercial assays can detect disease-induced immunity but may lack sensitivity for vaccine-induced immunity 1
- For quantitative determination of immunity status, glycoprotein-based ELISAs (gpELISA) have shown excellent sensitivity (100%) compared to the reference FAMA test 2
- Standard ELISAs using whole antigen extract have lower sensitivity (83% for natural infection, 78% for post-vaccination immunity) 2
Special Populations
Healthcare Workers
- All healthcare workers should be screened for varicella immunity
- Serologic screening before vaccination is cost-effective in healthcare settings 1
- Consider testing all unvaccinated healthcare personnel, regardless of disease history, as a small proportion with positive history may still be susceptible 1
Immunocompromised Patients
- Patients with inflammatory bowel disease or other immunocompromising conditions should be screened by:
- History of chickenpox or shingles
- Varicella zoster virus IgG testing if history is uncertain/negative 1
- Testing should be performed before initiating immunosuppressive therapy when possible
Post-Testing Management
- If positive for VZV IgG: Individual is considered immune to varicella
- If negative for VZV IgG:
- In healthy individuals: Vaccination with 2 doses of varicella vaccine at least 4 weeks apart is recommended
- In healthcare workers: Vaccination is strongly recommended to prevent nosocomial transmission 1
- In immunocompromised patients: Consider varicella zoster immune globulin (VZIG) for post-exposure prophylaxis 1
Common Pitfalls
False-positive results with LA testing: Using only a single concentration of serum with LA testing can lead to false positives, leaving individuals vulnerable to infection 1
Misinterpreting negative results after vaccination: Routine testing after vaccination is not recommended as commercial assays may not detect vaccine-induced immunity despite protection 1
Relying solely on patient-reported history: Self-reported history without healthcare provider verification may be unreliable; serological testing is preferred when history is uncertain 1
Timing of sample collection: Avoid testing samples that may contain passively acquired VZV IgG (e.g., after blood transfusion) 1
Using inappropriate tests: Using tests not optimized to detect antibody to the vaccine virus may lead to false negatives in vaccinated individuals 1
By following these evidence-based guidelines for checking varicella immunity, clinicians can accurately identify susceptible individuals and implement appropriate preventive measures to reduce morbidity and mortality from varicella infection.